Edgestream Partners’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.54M Buy
21,645
+12,277
+131% +$3.09M 0.15% 256
2025
Q4
$2.66M Buy
9,368
+2,469
+36% +$772K 0.07% 457
2025
Q3
$2.13M Buy
6,899
+6,073
+735% +$1.9M 0.06% 517
2025
Q2
$260K Buy
+826
New +$238K 0.01% 797
2024
Q3
Sell
-4,721
Closed -$953K 1029
2024
Q2
$953K Sell
4,721
-1,110
-19% -$200K 0.05% 535
2024
Q1
$999K Buy
5,831
+1,593
+38% +$297K 0.05% 499
2023
Q4
$920K Sell
4,238
-17,576
-81% -$3.01M 0.07% 466
2023
Q3
$3.48M Buy
21,814
+10,734
+97% +$2.4M 0.28% 61
2023
Q2
$3.19M Buy
+11,080
New +$3.37M 0.29% 74

Other funds holding PODD

Edgestream Partners's PODD Position: Q1 2026 in Review

Edgestream Partners increased its Insulet (PODD) stake by 131% in Q1 2026, buying an estimated $3.09M and bringing the position to 21,645 shares worth $4.54M. The position accounts for 0.15% of the portfolio, ranked #256.

Edgestream Partners first reported a position in PODD in Q2 2023 and has held it in 9 quarters since. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Edgestream Partners held 21,645 shares of Insulet worth $4.54M as of Q1 2026.
  • Edgestream Partners bought 12,277 Insulet shares in Q1 2026, an estimated $3.09M.
  • Insulet made up 0.15% of Edgestream Partners's portfolio in Q1 2026, its #256 holding.
  • Edgestream Partners first reported a position in Insulet in Q2 2023 and has held it in 9 quarters since.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Edgestream Partners's 13F filing for Q1 2026, filed 18 May 2026.